A landmark 2026 study links Tylenol use while pregnant to 41% smaller ovaries, 23% fewer ovarian follicles, and 13% smaller uteruses in infant girls. It is the latest research on the effects of acetaminophen, following explosive allegations by HHS Secretary Robert F. Kennedy Jr. that connected the popular OTC painkiller to autism & ADHD.
Published in Human Reproduction Open, the study followed 302 infant girls, measured acetaminophen in their mothers’ urine, and examined the girls by ultrasound. The authors describe it as the first human cohort designed specifically to study prenatal acetaminophen exposure and ovarian development.
The doses were not extreme: the median total reported dose across pregnancy was about 3 grams. The study reports a dose-response pattern, and a separate cohort of 1,210 girls showed lower uterine and ovarian volume at puberty. The authors note the design is observational and cannot establish causation.
Dr. Kelly Victory and epidemiologist Nicolas Hulscher join Dr. Drew to examine the findings and discuss pharma’s historic overmedication of women – now at the forefront of the Lindsay Clancy trial. Hulscher also presents new case report data showing Pfizer COVID-19 vaccine plasmid DNA recovered from a lethal “turbo cancer” heart tumor.
Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company with over 30 years of clinical experience. Follow at https://x.com/DrKellyVictory
Nicolas Hulscher, MPH is an epidemiologist and administrator for the McCullough Foundation. He holds a B.S. in Pre-Health Professional Studies from Oakland University’s Honors College and an MPH in epidemiology from the University of Michigan School of Public Health. Follow at https://x.com/NicHulscher
